Galileo Research Fact Sheet #132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

This pilot study investigated the effects of Galileo Therapy on fall-risk, muscle function and muscle power in patients with Multiple Sclerosis (MS) (25 patients, PDDS < 6.5).

Galileo Therapy was used only for 5 minutes 3 times per week over a period of 8 weeks. Despite the short therapy duration and the very simple protocol (20Hz, position 1.5, upright standing, 20° knee flexion) the Galileo Therapy showed a decreased fall-risk and significant improvements in balance (+12%), muscle function and muscle power (+12%) and torque at the knee (up to +15%).

These results are in line with other Galileo Studies like #GRFS112, #GRFS94 and #GRFS82 and they show how efficient and effective Galileo Therapy can be used in MS patients – especially when considering that the used protocol could have been significantly optimized by using different goal-specific exercises with intensity levels matched to the individual patient capabilities – which would result in even higher effects. Therapy - MS (Multiple Sclerosis)

#GRFS132 #GRFS